dermatan sulfate has been researched along with Brain Ischemia in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (63.16) | 18.2507 |
2000's | 5 (26.32) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, HP; Coffey, CS; Davis, PH; Froehler, MT; Jorge, RE; Leira, EC; Morton, SM | 1 |
Adams, HP; Biller, J | 1 |
Adams, HP; Clarke, WR; Ringman, JM; Saver, JL; Woolson, RF | 1 |
Ganesan, V; Pohl, KR; Wraige, E | 1 |
Bruno, A; Saha, C; Williams, LS | 1 |
Adams, HP; Bendixen, BH; Biller, J; Gordon, DL; Kappelle, LJ; Love, BB; Marsh, EE | 1 |
Adams, HP; Albanese, MA; Clarke, WR; Woolson, RF | 1 |
Magnani, HN; Ruys, AH | 1 |
Abedinpour, F; Berberich, R; Dumas, R; Egberts, JF; Gregoire, F; Jerkovic, M; Kutnowski, M; Nikolic, I; Woitinas, F; Zoeckler, S | 1 |
Wade, WE | 1 |
Adams, HP; Bendixen, BH; Chang, KC; Clarke, WR; Davis, PH; Hansen, MD; Leira, E; Woolson, RF | 1 |
Adams, HP; Chaturvedi, S; Woolson, RF | 1 |
Hanley, DF; Keyl, PM; McBee, NA; Razumovsky, AY; Ulatowski, JA; Varelas, PN; Wijman, CA; Williams, MA; Wityk, RJ | 1 |
Counsell, C; Sandercock, P | 1 |
Turpie, AG | 1 |
Adams, HP; Biller, J; Clarke, W; Woolson, RF | 1 |
Côte, R; Geerts, W; Gent, M; Ginsberg, JS; Jay, R; Leclerc, J; Levine, MN; Neemeh, J; Powers, PJ; Turpie, AG | 1 |
Adams, HP; Alberts, M; Biller, J; Bruno, A; Davis, JN; Goldstein, LB; Marler, JR; Massey, EW | 1 |
4 review(s) available for dermatan sulfate and Brain Ischemia
Article | Year |
---|---|
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.
Topics: Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Cost-Benefit Analysis; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; MEDLINE; Thrombophlebitis | 1998 |
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Topics: Acute Disease; Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Databases, Factual; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Odds Ratio; Pulmonary Embolism; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome; Venous Thrombosis | 2002 |
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1992 |
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group.
Topics: Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Factor Xa Inhibitors; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Incidence; Pilot Projects; Prothrombin; Thrombolytic Therapy; Treatment Outcome; United States | 1992 |
10 trial(s) available for dermatan sulfate and Brain Ischemia
Article | Year |
---|---|
Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Basal Ganglia; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Chondroitin Sulfates; Cohort Studies; Dermatan Sulfate; Dominance, Cerebral; Double-Blind Method; Drug Combinations; Female; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Perceptual Disorders; Risk Factors; Severity of Illness Index; Thalamus | 2004 |
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
Topics: Anticoagulants; Arteriosclerosis; Brain Ischemia; Cerebral Infarction; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Embolism; Glycosaminoglycans; Heparinoids; Heparitin Sulfate; Humans | 1993 |
Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
Topics: Brain Ischemia; Certification; Chondroitin Sulfates; Dermatan Sulfate; Education, Medical, Continuing; Fibrinolytic Agents; Glycosaminoglycans; Heparitin Sulfate; Humans; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome; United States | 1994 |
A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Thrombophlebitis; Treatment Outcome | 1994 |
Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
Topics: Anticoagulants; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Drug Combinations; Female; Fibrinolytic Agents; Functional Laterality; Glasgow Coma Scale; Heparitin Sulfate; Humans; Male; Placebos; Time Factors; Trauma Severity Indices; Treatment Outcome; Ultrasonography, Doppler, Duplex | 1999 |
Circadian variation in ischemic stroke subtypes.
Topics: Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Chondroitin Sulfates; Circadian Rhythm; Dermatan Sulfate; Forecasting; Heparitin Sulfate; Humans | 1999 |
Diagnostic impact of early transcranial Doppler ultrasonography on the TOAST classification subtype in acute cerebral ischemia.
Topics: Acute Disease; Aged; Antifibrinolytic Agents; Brain Ischemia; Cerebrovascular Circulation; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparitin Sulfate; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Risk Factors; Tomography, X-Ray Computed; Ultrasonography, Doppler, Transcranial | 2001 |
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1992 |
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group.
Topics: Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Factor Xa Inhibitors; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Incidence; Pilot Projects; Prothrombin; Thrombolytic Therapy; Treatment Outcome; United States | 1992 |
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antithrombin III; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombophlebitis | 1992 |
7 other study(ies) available for dermatan sulfate and Brain Ischemia
Article | Year |
---|---|
The NIHSS supplementary motor scale: a valid tool for multidisciplinary recovery trials.
Topics: Acute Disease; Anticoagulants; Brain Damage, Chronic; Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Dermatan Sulfate; Female; Glasgow Outcome Scale; Heparitin Sulfate; Humans; Male; Middle Aged; Motor Activity; Movement Disorders; Multicenter Studies as Topic; Prognosis; Recovery of Function; Retrospective Studies; Severity of Illness Index; Stroke; Stroke Rehabilitation; Treatment Outcome | 2013 |
Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification.
Topics: Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Heparitin Sulfate; History, 20th Century; Humans; Stroke | 2015 |
A proposed classification for subtypes of arterial ischaemic stroke in children.
Topics: Adolescent; Anemia, Sickle Cell; Brain Ischemia; Carotid Artery, Internal, Dissection; Cerebral Infarction; Child; Child, Preschool; Chondroitin Sulfates; Data Collection; Dermatan Sulfate; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Male; Moyamoya Disease; Reproducibility of Results; Review Literature as Topic; Severity of Illness Index; Stroke | 2005 |
Using change in the National Institutes of Health Stroke Scale to measure treatment effect in acute stroke trials.
Topics: Acute Disease; Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Cohort Studies; Data Interpretation, Statistical; Dermatan Sulfate; Heparitin Sulfate; Humans; National Institutes of Health (U.S.); Odds Ratio; Placebos; Regression Analysis; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome; United States | 2006 |
Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
Topics: Acute Disease; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic | 1994 |
Immediate use of anticoagulants may not improve stroke outcomes.
Topics: Anticoagulants; Brain Ischemia; Cerebral Hemorrhage; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparitin Sulfate; Humans; Time Factors; Treatment Outcome; United States | 1998 |
Large-dose infusions of heparinoid ORG 10172 in ischemic stroke.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Injections, Intravenous; Middle Aged; Pilot Projects | 1990 |